Background Depression is a risk factor and complication of coronary artery disease (CAD) that is associated with poor ...
La Jolla scientists are stepping into a national push to get new medicines from lab bench to bedside faster. The project, ...
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA), ...
The new Emerson DeltaV PKM library reportedly cuts months from drug development by providing pre-built specification elements ...
The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...
Knowledge graphs are a powerful tool for bringing together information from biological databases and linking what is already ...
Planned SAD and MAD Studies Mark Key Clinical Inflection Point for Intranasal PTSD and Anxiety SARASOTA, FL, Dec. 30, 2025 (GLOBE NEWSWIRE) -- ...
The biotech firm focused on fighting breast cancer was recently selected to the prestigious Charles River Cell & Gene Therapy ...
Background Amyloid transthyretin (ATTR) amyloidosis is a rare, life-threatening disease frequently manifesting with ...
Live Science on MSN
A fentanyl vaccine enters human trials in 2026 — here's how it works
A vaccine in development would be the first proactive treatment for overdose and fentanyl addiction, if approved. A vaccine ...
The research represents a major step forward in revealing how the three dimensional form of DNA shapes the way human biology functions. In a major step toward understanding how the physical form of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback